Urticaria is a common clinical condition presenting with wheals (hives), angioedema, or
both. Urticaria has a complex pathogenesis, along with a high disease burden, a significant …

Background and objective Numerous autoimmune diseases (AIDs) have been linked to
chronic spontaneous urticaria (CSU). Here, we provide the first extensive and …

Background Omalizumab is an effective and well‐tolerated treatment for chronic
spontaneous urticaria (CSU). Markers and predictors of response are largely unknown, but …

Patients with chronic spontaneous urticaria (CSU) are widely held to often have other
autoimmune disorders, including autoimmune thyroid disease. Here, we systematically …

Chronic spontaneous urticaria (CSU) is defined as persistent wheals, angioedema, or both
lasting for> 6 weeks due to known or unknown causes. Some epidemiological studies and …

Chronic spontaneous urticaria (CSU) is often associated with organ specific autoimmunity
but is rarely caused by food allergy. Colourings and preservatives in pre-packaged foods, so …

Background Cold urticaria is a subtype of chronic inducible urticaria (CIndU) associated with
significant morbidity and a risk for anaphylaxis. Few studies have assessed the prevalence …

Chronic viral infections including those by hepatitis B (CHB) virus and hepatitis C (CHC)
virus have been reported to be comorbidities of chronic spontaneous urticaria (CSU). Here …

Omalizumab is a recombinant humanized anti-Ig E monoclonal antibody used as the third
line treatment of chronic spontaneous urticaria (CSU). We report four patients with severe …

The cause of chronic urticaria remains often elusive. The association between chronic
urticaria and intake of medications have been reported in children. However, the causative …